Skip to main content

House Dust Mite, Dermatophagoides farinae, House Dust Mite, Dermatophagoides pteronyssinus

Unverified·never
Manufacturer
ALK
ICD-10 indication
J30.81

Affordability Check

How much will you actually pay for House Dust Mite, Dermatophagoides farinae, House Dust Mite, Dermatophagoides pteronyssinus?

In 30 seconds, see every legitimate way to afford House Dust Mite, Dermatophagoides farinae, House Dust Mite, Dermatophagoides pteronyssinus — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About House Dust Mite, Dermatophagoides farinae, House Dust Mite, Dermatophagoides pteronyssinus

What is this medication? This medication is a form of allergen immunotherapy designed to treat patients suffering from allergic rhinitis, with or without conjunctivitis, caused by house dust mites. It specifically contains extracts from two common species, Dermatophagoides farinae and Dermatophagoides pteronyssinus. By introducing controlled amounts of these allergens to the immune system, the medication helps the body develop a tolerance over time. This process is intended to reduce the frequency and severity of symptoms such as sneezing, nasal congestion, and itchy eyes when the patient is naturally exposed to dust mites in their daily environment.

Doctors typically prescribe this treatment for individuals who have not found sufficient relief from standard allergy medications like antihistamines or nasal steroids. It is usually administered as a sublingual tablet that dissolves under the tongue, allowing the allergens to be absorbed directly through the mucous membranes. Because this therapy aims to modify the underlying immune response rather than just providing temporary symptom relief, it is considered a long-term management strategy for chronic allergies. Patients generally require a confirmed diagnosis through clinical testing before beginning this specific immunotherapy regimen.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.